...
首页> 外文期刊>Journal of aerosol medicine and pulmonary drug delivery >Clinical practice of nebulized therapy in china: A national questionnaire survey
【24h】

Clinical practice of nebulized therapy in china: A national questionnaire survey

机译:中国雾化疗法的临床实践:国家问卷调查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Despite having been used in the clinical practice of respiratory diseases for decades in China, the overall description of nebulized therapy has not been reported to date. The purpose of this study was to investigate the basic characteristics and information on the application of nebulized therapy in the clinical practice of respiratory diseases in China.Methods: A questionnaire survey with 17 questions relating to nebulized therapy was carried out in three levels (tertiary, secondary, and primary) of hospitals throughout mainland China. The perspectives of various professional degrees of the medical staffs from different levels of hospitals were further studied.Results: A total of 6,449 effective questionnaires were collected from 1,328 hospitals or clinics located in 27 provinces or autonomous regions of mainland China. Nebulized therapy was applied in 91.1% of the hospitals, significantly more in tertiary and secondary levels of hospitals than in the primary level of hospitals. Jet and ultrasonic nebulizers were used in 53.3% and 47.7% of the hospitals, respectively. Only 50.8% of the responders identified the brands of the devices. 82.5 Percent of the responders had prescribed nebulized therapy. 68.8 Percent and 41.5% of responders agreed that nebulized therapy can be used for the treatment of asthma and COPD, respectively. 86.5 Percent of responders agreed that nebulized therapy can be used for patients with acute exacerbation, whereas 27.5% stated that it can be used for stable patients. The most commonly used medicines were short-acting bronchodilators, followed by corticosteroids, mucolytics, and antibiotics. 17.2 Percent of the responders reported adverse events of nebulized therapy experienced by the patients. Continuous medical education and training on nebulized therapy were required by 72.1% of responders.Conclusions: The present national survey, firstly, provided the basic characteristics and information on the application of nebulizer therapy in the clinical practice of respiratory diseases in China. Certainly, this will help facilitate nebulized therapy, especially in the community hospitals. Continuous medical education and technical training are essential to improve the clinical application of nebulized therapy.
机译:背景:尽管在中国呼吸道疾病的临床实践中已使用了数十年,但迄今为止尚未报道雾化疗法的总体描述。本研究旨在探讨雾化疗法在中国呼吸系统疾病临床实践中应用的基本特征和信息。方法:问卷调查分三个层次(三级,二级和一级医院)。结果:从中国27个省或自治区的1328家医院或诊所中,共收集了6449份有效问卷。 91.1%的医院采用了雾化疗法,三级和二级医院的雾化治疗明显多于一级医院。分别有53.3%和47.7%的医院使用了喷射雾化器和超声波雾化器。只有50.8%的响应者确定了设备的品牌。 82.5%的响应者开了雾化治疗处方。 68.8%的响应者和41.5%的响应者同意,雾化疗法可分别用于治疗哮喘和COPD。 86.5%的回应者同意雾化疗法可用于急性加重患者,而27.5%的人表示雾化疗法可用于病情稳定的患者。最常用的药物是短效支气管扩张药,其次是皮质类固醇,粘液溶解剂和抗生素。 17.2%的反应者报告患者经历了雾化治疗的不良事件。 72.1%的受访者需要对雾化疗法进行持续医学教育和培训。结论:本次全国调查首先提供了雾化疗法在中国呼吸系统疾病临床实践中应用的基本特征和信息。当然,这将有助于促进雾化治疗,尤其是在社区医院。持续的医学教育和技术培训对于改善雾化疗法的临床应用至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号